Trial intelligence / Profile preview

High-Dose Vitamin D for Vitamin D Deficiency Following Severe Burns in Children

NCT00591604Phase 3Withdrawn

Sponsor
The University of Texas Medical Branch at Galveston
Start
Feb 2007
Primary completion
Mar 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Phase 3, single-arm trial of vitamin d in Vitamin D deficiency (VDD), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Increase in overall bone health at 12 weeks. Planned start Feb 2007; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT00591604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00591604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call